Identification of a novel common proviral integration site, flit-1, in feline leukemia virus induced thymic lymphoma

被引:8
|
作者
Fujino, Yasuhito [1 ,2 ]
Liao, Chun-Peng [3 ]
Zhao, Yan Shi [2 ]
Pan, Judong [2 ]
Mathes, Lawrence E. [4 ,5 ]
Hayes, Kathleen A. [4 ,5 ]
Ohno, Koichi [1 ]
Tsujimoto, Hajime [1 ]
Roy-Burman, Pradip [2 ,3 ]
机构
[1] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, Tokyo 1138657, Japan
[2] Univ So Calif, Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
[3] Univ So Calif, Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA
[4] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA
[5] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA
关键词
Retrovirus; Insertional mutagenesis; ACVRL1/ALK1; RETROVIRAL INSERTIONAL MUTAGENESIS; C-MYC; CELL-LINE; GENE; CONSERVATION; ACTIVIN; FLVI-2; TUMORS; LYMPHOSARCOMAS; EXPRESSION;
D O I
10.1016/j.virol.2009.01.021
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A new proviral integration site for feline leukemia virus (FeLV), termed flit-1, was identified from feline thymic lymphoma. Among 35 FeLV-related tumors examined, 5 of 25 thymic lymphomas demonstrated proviral insertion within flit-1 locus whereas none of four alimentary and five multicentric lymphomas and one T-lymphoid leukemia examined had rearrangement in this region. Extensive sequence analysis has shown that flit-1, which is noncoding, is conserved on human chromosome 12 and mouse chromosome 15. The human and murine homologs of flit-1 are positioned approximately 30-kb upstream to activin-A receptor type II-like 1 (ACVRL1/ALK1) gene. Expression of ACVRL1 mRNA was examined in two of five lymphomas with flit-1 rearrangement and detected in both of the two whereas normal thymuses and seven lymphoid tumors without flit-1 rearrangement had no detectable expression. Therefore, flit-1 appears to represent a novel FeLV proviral common integration domain that may influence lymphomagenesis as insertional mutagenesis. (c) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 39 条
  • [21] Rational Evolution of a Novel Type of Potent and Selective Proviral Integration Site in Moloney Murine Leukemia Virus Kinase 1 (PIM1) Inhibitor from a Screening-Hit Compound
    Nakano, Hirofumi
    Saito, Nae
    Parker, Lorien
    Tada, Yukio
    Abe, Masanao
    Tsuganezawa, Keiko
    Yokoyama, Shigeyuki
    Tanaka, Akiko
    Kojima, Hirotatsu
    Okabe, Takayoshi
    Nagano, Tetsuo
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5151 - 5164
  • [22] Expression and Function of Proviral Integration Site for Moloney Murine Leukemia Virus 1 (PIM-1) Kinase in Rheumatoid Arthritis Fibroblast-like Synoviocytes
    Choi, Yong Seok
    Ha, You Jung
    Hur, Jaehyung
    Kang, Eun Ha
    Song, Yeong Wook
    Lee, Yun Jong
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [23] Proviral integration site for Moloney murine leukemia virus-1 (PIM-1) inhibition with AZD1208 to prevent resistance to osimertinib in EGFR mutant NSCLC
    Bracht, J.
    Karachaliou, N.
    Berenguer, J.
    Attili, I.
    Ito, M.
    Codony-Servat, C.
    Codony-Servat, J.
    Filipska, M.
    Gil, N.
    Rosell, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S13 - S13
  • [24] Proviral integration site for Moloney murine leukemia virus 1, but not phosphatidylinositol-3 kinase, is essential in the antiapoptotic signaling cascade initiated by IL-5 in eosinophils
    Andina, Nicola
    Didichenko, Svetlana
    Schmidt-Mende, Jan
    Dahinden, Clemens A.
    Simon, Hans-Uwe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (03) : 603 - 611
  • [25] Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites
    Joosten, M
    Vankan-Berkhoudt, Y
    Tas, M
    Lunghi, M
    Jenniskens, Y
    Parganas, E
    Valk, PJ
    Löwenberg, B
    van den Akker, E
    Delwel, R
    ONCOGENE, 2002, 21 (47) : 7247 - 7255
  • [26] Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites
    Marieke Joosten
    Yolanda Vankan-Berkhoudt
    Marjolein Tas
    Monja Lunghi
    Yvonne Jenniskens
    Evan Parganas
    Peter JM Valk
    Bob Löwenberg
    Eric van den Akker
    Ruud Delwel
    Oncogene, 2002, 21 : 7247 - 7255
  • [27] Nm23-m2 is a proto-oncogene involved in leukemia, and located in the novel common virus integration site Ev113.
    Joosten, M
    Vankan, Y
    Lunghi, M
    Valk, P
    van den Broek, M
    Lowenberg, B
    Delwel, R
    BLOOD, 1999, 94 (10) : 57A - 57A
  • [28] Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: Negative effect of nuclear factor 1 binding site
    Ethelberg, S
    Hallberg, B
    Lovmand, J
    Schmidt, J
    Luz, A
    Grundstrom, T
    Pedersen, FS
    JOURNAL OF VIROLOGY, 1997, 71 (02) : 1196 - 1206
  • [29] Gris1, a new common integration site in Graffi murine leukemia virus-induced leukemias:: Overexpression of a truncated cyclin D2 due to alternative splicing
    Denicourt, C
    Kozak, CA
    Rassart, E
    JOURNAL OF VIROLOGY, 2003, 77 (01) : 37 - 44
  • [30] Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapy
    Nishida, Yuki
    Maeda, Aya
    Chachad, Dhruv
    Ishizawa, Jo
    Qiu, Yi Hua
    Kornblau, Steven M.
    Kimura, Shinya
    Andreeff, Michael
    Kojima, Kensuke
    CANCER SCIENCE, 2015, 106 (12) : 1705 - 1713